Natures Sunshine Products Inc (NATR)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ
Market Cap: $179.53M
Last updated: Nov 17, 2026 at 11:03 AM ET
Natures Sunshine Products Inc (NATR) Financials: Revenue, Profit and Cash Flow
Natures Sunshine Products reported revenue of $480.14M for the fiscal year ended Dec 31, 2025, up 5.7% from the year before. That year, net income was $19.52M with a net margin of 4.1%, operating cash flow was $35.32M and free cash flow was $28.84M. The quarter ended Sep 30, 2026 had revenue of $116.60M and net income of $1.89M.
Revenue and Margins
The operating margin was 5.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $341.16M, a compound annual rate of 3.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $480.14M | +5.7% | 72.4% | 5.2% | 4.1% |
| Dec 2024 | $454.36M | +2.0% | 71.5% | 4.4% | 1.7% |
| Dec 2023 | $445.32M | +5.5% | 72.1% | 4.2% | 3.7% |
| Dec 2022 | $421.91M | -5.0% | 71.0% | 3.9% | 0.1% |
| Dec 2021 | $444.08M | +15.3% | 74.0% | 7.8% | 6.8% |
| Dec 2020 | $385.20M | +6.3% | 73.7% | 5.6% | 6.0% |
| Dec 2019 | $362.21M | -0.7% | 74.1% | 4.5% | 1.9% |
| Dec 2018 | $364.81M | +6.7% | 73.8% | 1.5% | -0.3% |
| Dec 2017 | $342.03M | +0.3% | 73.4% | 0.4% | -4.0% |
| Dec 2016 | $341.16M | N/A | 73.3% | 2.9% | 0.2% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 147.4% from the year before. In the quarter ended Sep 2026, net income fell 65.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $480.14M | $454.36M | $445.32M | $421.91M | $444.08M | $385.20M | $362.21M | $364.81M | $342.03M | $341.16M |
| Cost of revenue | $132.42M | $129.68M | $124.19M | $122.15M | $115.47M | $101.28M | $93.94M | $95.69M | $91.04M | $90.94M |
| Gross profit | $347.72M | $324.69M | $321.13M | $299.76M | $328.62M | $283.93M | $268.27M | $269.12M | $250.99M | $250.22M |
| Research and development | $1.90M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $24.74M | $20.09M | $18.75M | $16.26M | $34.67M | $21.48M | $16.13M | $5.35M | $1.39M | $10.04M |
| Net income | $19.52M | $7.89M | $16.42M | $550.00K | $30.21M | $22.96M | $6.93M | -$1.20M | -$13.82M | $675.00K |
| EBITDA | $43.75M | $38.03M | $35.95M | $26.37M | $42.77M | $33.49M | $26.02M | $13.39M | $12.14M | $14.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.60M | $116.98M | $122.89M | $123.81M | $128.34M | $114.75M | $113.25M | $118.20M | $114.61M | $110.55M | $110.99M | $108.94M |
| Gross profit | $84.96M | $86.17M | $89.98M | $89.78M | $94.05M | $82.30M | $81.60M | $85.06M | $81.76M | $78.89M | $78.98M | $78.32M |
| Operating income | $5.28M | $5.48M | $9.54M | $5.32M | $8.97M | $4.27M | $6.17M | $4.55M | $5.28M | $5.64M | $4.62M | $5.71M |
| Net income | $1.89M | $3.54M | $5.12M | $4.11M | $5.54M | $5.52M | $4.88M | -$732.00K | $4.65M | $1.49M | $2.49M | $9.34M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $3.27M by $90.62M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $261.15M | $240.85M | $249.77M | $229.78M | $258.87M | $249.50M | $213.07M | $193.02M | $195.19M | $205.57M |
| Current assets | $178.84M | $160.58M | $165.82M | $149.51M | $164.67M | $154.06M | $112.70M | $106.83M | $102.51M | $94.50M |
| Cash and equivalents | $93.89M | $84.70M | $82.37M | $60.03M | $86.18M | $92.07M | $53.63M | $50.64M | $42.91M | $32.28M |
| Total liabilities | $99.59M | $79.86M | $90.23M | $82.73M | $97.47M | $92.26M | $83.63M | $72.45M | $75.46M | $73.17M |
| Short-term debt | $3.27M | $3.93M | $4.55M | $1.17M | $1.55M | $2.51M | $1.52M | $1.53M | $506.00K | $9.92M |
| Long-term debt | N/A | N/A | N/A | N/A | $1.17M | $2.42M | $0 | N/A | $13.18M | $0 |
| Shareholder equity | $161.55M | $155.31M | $154.06M | $142.91M | $158.20M | $155.39M | $129.21M | $120.50M | $119.32M | $131.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $268.23M | $259.82M | $261.46M | $261.15M | $264.81M | $254.88M | $252.70M | $240.85M | $245.33M | $235.83M | $247.27M | $249.77M |
| Total liabilities | $96.55M | $90.51M | $94.54M | $99.59M | $98.10M | $91.19M | $85.60M | $79.86M | $82.72M | $79.43M | $87.56M | $90.23M |
| Cash and equivalents | $89.38M | $82.50M | $87.58M | $93.89M | $95.55M | $81.34M | $86.49M | $84.70M | $78.70M | $68.69M | $77.77M | $82.37M |
| Shareholder equity | $171.68M | $169.32M | $166.92M | $161.55M | $160.50M | $157.68M | $161.28M | $155.31M | $156.53M | $150.61M | $154.06M | $154.06M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 81.7% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $35.32M | $25.30M | $41.23M | $710.00K | $34.61M | $37.66M | $8.54M | $21.83M | $10.52M | $3.42M |
| Capital expenditures | $6.48M | $10.97M | $10.48M | $7.63M | $6.67M | $4.91M | $5.10M | $4.83M | $5.50M | $11.03M |
| Free cash flow | $28.84M | $14.33M | $30.75M | -$6.92M | $27.94M | $32.75M | $3.44M | $17.00M | $5.02M | -$7.61M |
| Dividends paid | N/A | N/A | N/A | $3.10M | $19.86M | $0 | $19.86M | $19.86M | $1.85M | $7.51M |
| Share repurchases | N/A | $8.86M | $6.40M | $13.57M | $7.42M | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$6.48M | -$10.97M | -$10.48M | -$7.63M | -$6.61M | -$4.91M | -$5.10M | $211.00K | -$3.20M | -$11.53M |
| Financing cash flow | -$23.77M | -$9.90M | -$7.96M | -$16.25M | -$31.72M | $3.88M | -$63.00K | -$12.19M | $1.57M | -$286.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.75M | $835.00K | -$1.85M | $9.90M | $18.47M | $4.34M | $2.61M | $12.18M | $9.62M | $1.30M | $2.19M | $9.60M |
| Capital expenditures | $1.54M | $2.78M | $2.48M | $2.34M | $1.68M | $1.35M | $1.11M | $2.19M | $1.74M | $3.35M | $3.69M | $1.25M |
| Free cash flow | $9.21M | -$1.94M | -$4.33M | $7.56M | $16.79M | $2.99M | $1.50M | $9.99M | $7.88M | -$2.05M | -$1.50M | $8.35M |
Frequently Asked Questions About NATR
What is Natures Sunshine Products' annual revenue?
Natures Sunshine Products reported revenue of $480.14M for the fiscal year ended Dec 31, 2025.
How fast is Natures Sunshine Products' revenue growing?
Revenue was up 5.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.4%.
Is Natures Sunshine Products profitable?
Yes. Natures Sunshine Products reported net income of $19.52M for the fiscal year ended Dec 31, 2025, with a net margin of 4.1%.
How much free cash flow does NATR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $35.32M minus capital expenditures of $6.48M produced free cash flow of $28.84M.
How much debt does Natures Sunshine Products have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $3.27M and cash and equivalents of $93.89M.
NATR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors